Henderson Molly
Insider CIK 1363812 · ADXS Executive Vice President & CFO · VSCP Chief Business/Financial Off. · LBIO Chief Financial Officer · URGN Chief Financial Officer · PHAT CFO and CBO
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| PHAT Phathom Pharmaceuticals, I | S Sale | 2025-04-07 | 2025-04-08 | 3,678 | $4.55 | $16.7K | 89,868 | SEC↗ |
| PHAT Phathom Pharmaceuticals, I | A Award deriv | 2025-02-27 | 2025-03-03 | 50,000 | — | $0 | 50,000 | SEC↗ |
| PHAT Phathom Pharmaceuticals, I | A Award | 2025-02-27 | 2025-03-03 | 72,000 | — | $0 | 165,546 | SEC↗ |
| PHAT Phathom Pharmaceuticals, I | S Sale | 2025-01-21 | 2025-01-23 | 6,583 | $6.59 | $43.4K | 93,546 | SEC↗ |
| PHAT Phathom Pharmaceuticals, I | S Sale | 2024-12-19 | 2024-12-20 | 1,291 | $8.00 | $10.3K | 98,156 | SEC↗ |
| PHAT Phathom Pharmaceuticals, I | S Sale | 2024-07-15 | 2024-07-17 | 4,325 | $11.72 | $50.7K | 99,447 | SEC↗ |
| PHAT Phathom Pharmaceuticals, I | A Award | 2024-05-31 | 2024-05-31 | 7,500 | — | $0 | 102,763 | SEC↗ |
| PHAT Phathom Pharmaceuticals, I | S Sale | 2024-04-08 | 2024-04-10 | 3,435 | $11.10 | $38.1K | 95,263 | SEC↗ |
| PHAT Phathom Pharmaceuticals, I | S Sale | 2024-01-19 | 2024-01-22 | 6,307 | $7.75 | $48.9K | 98,698 | SEC↗ |
| PHAT Phathom Pharmaceuticals, I | A Award deriv | 2024-01-18 | 2024-01-22 | 120,000 | — | $0 | 120,000 | SEC↗ |
| PHAT Phathom Pharmaceuticals, I | S Sale | 2023-11-20 | 2023-11-21 | 2,127 | $7.24 | $15.4K | 103,061 | SEC↗ |
| PHAT Phathom Pharmaceuticals, I | S Sale | 2023-11-01 | 2023-11-03 | 11,681 | $8.95 | $104.5K | 105,188 | SEC↗ |
| PHAT Phathom Pharmaceuticals, I | S Sale | 2023-11-01 | 2023-11-03 | 811 | $7.80 | $6.3K | 116,869 | SEC↗ |
| PHAT Phathom Pharmaceuticals, I | A Award | 2023-11-01 | 2023-11-03 | 22,500 | — | $0 | 117,680 | SEC↗ |
| PHAT Phathom Pharmaceuticals, I | A Award | 2023-07-14 | 2023-07-17 | 25,000 | $1.00 | $25.0K | 95,180 | SEC↗ |
| PHAT Phathom Pharmaceuticals, I | A Award | 2023-07-14 | 2023-07-21 | 25,000 | — | $0 | 95,180 | SEC↗ |
| PHAT Phathom Pharmaceuticals, I | S Sale | 2023-06-02 | 2023-06-05 | 1,960 | $11.41 | $22.4K | 68,506 | SEC↗ |
| PHAT Phathom Pharmaceuticals, I | S Sale | 2023-05-22 | 2023-05-23 | 2,110 | $12.87 | $27.2K | 70,466 | SEC↗ |
| PHAT Phathom Pharmaceuticals, I | S Sale | 2023-04-06 | 2023-04-07 | 3,439 | $7.27 | $25.0K | 72,576 | SEC↗ |
| PHAT Phathom Pharmaceuticals, I | S Sale | 2023-03-01 | 2023-03-03 | 2,032 | $8.53 | $17.3K | 76,015 | SEC↗ |
| PHAT Phathom Pharmaceuticals, I | A Award deriv | 2023-01-19 | 2023-01-20 | 55,000 | — | $0 | 55,000 | SEC↗ |
| PHAT Phathom Pharmaceuticals, I | A Award | 2023-01-19 | 2023-01-20 | 33,000 | — | $0 | 78,047 | SEC↗ |
| PHAT Phathom Pharmaceuticals, I | S Sale | 2022-11-21 | 2022-11-23 | 2,159 | $9.60 | $20.7K | 43,341 | SEC↗ |
| PHAT Phathom Pharmaceuticals, I | A Award | 2022-09-01 | 2022-09-02 | 7,500 | — | $0 | 45,500 | SEC↗ |
| PHAT Phathom Pharmaceuticals, I | A Award | 2022-05-19 | 2022-05-20 | 12,000 | — | $0 | 38,000 | SEC↗ |
| PHAT Phathom Pharmaceuticals, I | P Buy | 2022-05-13 | 2022-05-16 | 6,000 | — | $0 | 26,000 | SEC↗ |
| PHAT Phathom Pharmaceuticals, I | A Award deriv | 2022-04-05 | 2022-04-06 | 100,000 | — | $0 | 100,000 | SEC↗ |
| PHAT Phathom Pharmaceuticals, I | A Award | 2022-04-05 | 2022-04-06 | 20,000 | — | $0 | 20,000 | SEC↗ |
| URGN UroGen Pharma Ltd. | A Award deriv | 2022-01-31 | 2022-02-02 | 7,500 | — | $0 | 7,500 | SEC↗ |
| URGN UroGen Pharma Ltd. | A Award deriv | 2022-01-31 | 2022-02-02 | 30,000 | — | $0 | 30,000 | SEC↗ |
| URGN UroGen Pharma Ltd. | M Exercise deriv | 2022-01-31 | 2022-02-02 | 666 | — | $0 | 1,334 | SEC↗ |
| URGN UroGen Pharma Ltd. | M Exercise | 2022-01-31 | 2022-02-02 | 666 | — | $0 | 5,579 | SEC↗ |
| URGN UroGen Pharma Ltd. | S Sale | 2022-01-31 | 2022-02-02 | 331 | $7.58 | $2.5K | 5,248 | SEC↗ |
| URGN UroGen Pharma Ltd. | M Exercise deriv | 2021-11-30 | 2021-12-02 | 5,000 | — | $0 | 10,000 | SEC↗ |
| URGN UroGen Pharma Ltd. | M Exercise | 2021-11-30 | 2021-12-02 | 5,000 | — | $0 | 7,500 | SEC↗ |
| URGN UroGen Pharma Ltd. | S Sale | 2021-11-30 | 2021-12-02 | 2,587 | $12.03 | $31.1K | 4,913 | SEC↗ |
| URGN UroGen Pharma Ltd. | A Award deriv | 2021-06-05 | 2021-06-08 | 15,000 | — | $0 | 15,000 | SEC↗ |
| URGN UroGen Pharma Ltd. | P Buy | 2021-05-17 | 2021-05-18 | 2,500 | $15.85 | $39.6K | 2,500 | SEC↗ |
| URGN UroGen Pharma Ltd. | A Award deriv | 2021-01-31 | 2021-02-02 | 6,000 | — | $0 | 6,000 | SEC↗ |
| URGN UroGen Pharma Ltd. | A Award deriv | 2021-01-31 | 2021-02-02 | 2,000 | — | $0 | 2,000 | SEC↗ |
| URGN UroGen Pharma Ltd. | A Award deriv | 2020-10-01 | 2020-10-05 | 60,000 | — | $0 | 60,000 | SEC↗ |
| URGN UroGen Pharma Ltd. | A Award deriv | 2020-10-01 | 2020-10-05 | 15,000 | — | $0 | 15,000 | SEC↗ |
| ADXS Advaxis, Inc. | A Award deriv | 2020-05-04 | 2020-05-05 | 50,000 | — | $0 | 50,000 | SEC↗ |
| ADXS Advaxis, Inc. | A Award deriv | 2019-10-24 | 2019-10-25 | 25,000 | — | $0 | 25,000 | SEC↗ |
| ADXS Advaxis, Inc. | A Award | 2019-04-11 | 2019-04-11 | 2,500 | $3.68 | $9.2K | 5,833 | SEC↗ |
| ADXS Advaxis, Inc. | A Award | 2019-04-09 | 2019-04-10 | 2,900 | $3.86 | $11.2K | 2,900 | SEC↗ |
| ADXS Advaxis, Inc. | A Award | 2019-04-09 | 2019-04-10 | 100 | $3.85 | $385 | 100 | SEC↗ |
| ADXS Advaxis, Inc. | A Award deriv | 2018-11-05 | 2018-11-07 | 125,000 | — | $0 | 125,000 | SEC↗ |
| ADXS Advaxis, Inc. | A Award | 2018-06-12 | 2018-06-13 | 5,000 | $1.89 | $9.4K | 5,000 | SEC↗ |
| ADXS Advaxis, Inc. | A Award deriv | 2018-06-06 | 2018-06-08 | 250,000 | — | $0 | 250,000 | SEC↗ |
| LBIO Lion Biotechnologies, Inc. | A Award deriv | 2016-06-10 | 2016-06-15 | 50,000 | — | $0 | 50,000 | SEC↗ |
| LBIO Lion Biotechnologies, Inc. | A Award deriv | 2016-06-01 | 2016-06-15 | 150,000 | — | $0 | 150,000 | SEC↗ |
| LBIO Lion Biotechnologies, Inc. | A Award deriv | 2016-03-11 | 2016-03-15 | 100,000 | — | $0 | 100,000 | SEC↗ |
| LBIO Lion Biotechnologies, Inc. | A Award deriv | 2015-12-28 | 2015-12-30 | 21,116 | — | $0 | 21,116 | SEC↗ |
| LBIO Lion Biotechnologies, Inc. | A Award deriv | 2015-06-08 | 2015-06-10 | 200,000 | — | $0 | 200,000 | SEC↗ |
| VSCP VirtualScopics, Inc. | A Award deriv | 2013-01-29 | 2013-02-11 | 39,348 | — | $0 | 39,348 | SEC↗ |
| VSCP VirtualScopics, Inc. | P Buy | 2012-06-19 | 2012-06-21 | 8,000 | $0.90 | $7.2K | 14,400 | SEC↗ |
| VSCP VirtualScopics, Inc. | O Exercise OTM deriv | 2012-01-27 | 2012-01-30 | 12,500 | $1.13 | $14.1K | 1,219,772 | SEC↗ |
| VSCP VirtualScopics, Inc. | O Exercise OTM deriv | 2012-01-27 | 2012-01-30 | 12,500 | $1.13 | $14.1K | 1,244,772 | SEC↗ |
| VSCP VirtualScopics, Inc. | O Exercise OTM deriv | 2012-01-27 | 2012-01-30 | 12,500 | $1.13 | $14.1K | 1,232,272 | SEC↗ |
| VSCP VirtualScopics, Inc. | O Exercise OTM deriv | 2012-01-27 | 2012-01-30 | 12,500 | $1.13 | $14.1K | 1,207,272 | SEC↗ |